Tags
- A
- China
- Drug
- Drug development
- Drug discovery
- Fenfluramine
- Fenfluramine/phentermine
- Gastric inhibitory polypeptide
- Hanmi Pharmaceutical
- Korean
- Management of obesity
- Medicine
- Multifactorial
- New
- New drug development
- Obesity
- Partnership
- Pharma
- Pharma companies
- Phentermine
- Phentermine/topiramate
- Precision
- Precision medicine
- Setmelanotide
- South Korean
- Targeting